Application of Pyrrolidine in FDA‐Approved Drugs
Medicinal Research Reviews · 18.08.2026
DOI: 10.1002/med.70100 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Medicinal Research Reviews, online erschienen am 18.08.2026. Verfasst von Jiao Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, The First Hospital of China Medical University, Shenyang, Liaoning, China. Die Arbeit nennt 157 Literaturangaben. Gefördert von: Liaoning Province Science and Technology Plan Joint Program, General Program of Liaoning Provincial Natural Science Foundation.
Abstract (Originalsprache)
The saturated five‐membered pyrrolidine ring is a privileged scaffold in medicinal chemistry. There is great interest in the pyrrolidine skeleton due to several key characteristics of this heterocyclic ring: its sp 3 hybridized carbon framework, the contribution of multiple chiral centers, and the inherent planarization of the ring, typically manifested as conformational flexibility or pseudorotation. These characteristics make pyrrolidine‐based structures highly attractive in the drug design for various biological targets. The pyrrolidine moiety also enhances drug‐like properties such as metabolic stability, water solubility, and modulation of basicity, and can interact favorably with a wide range of biological targets through specific stereochemical interactions. This review surveys the synthesis and clinical applications of FDA‐approved pyrrolidine‐containing drugs since 2014, with the aim of informing the rational design of next‐generation pyrrolidine‐based therapeutics.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Anesthesiology, The First Hospital of China Medical University, Shenyang, Liaoning, China.
- Department of Rehabilitation, Shengjing Hospital of China Medical University, Shenyang, Liaoning, China.
- Department of Obstetrics and Gynecology, Shengjing Hospital of China Medical University, Shenyang, Liaoning, China.
- Rega Institute of Medical Research, KU Leuven, Leuven, Belgium.
- Department of Gastroenterology, Shengjing Hospital of China Medical University, Shenyang, Liaoning, China.
ORCID-Profile: Qifang Liu
Förderung
- Liaoning Province Science and Technology Plan Joint Program
- General Program of Liaoning Provincial Natural Science Foundation
Zitieren
APA
Wang, J., Tan, X., Wang, X., Wang, Y., Li, H., Yu, Z., & Liu, Q. (2026). Application of Pyrrolidine in FDA‐Approved Drugs. Medicinal Research Reviews. https://doi.org/10.1002/med.70100
Vancouver
Wang J, Tan X, Wang X, Wang Y, Li H, Yu Z, et al. Application of Pyrrolidine in FDA‐Approved Drugs. Medicinal Research Reviews. 2026. doi:10.1002/med.70100
BibTeX
@article{Wang2026,
author = {Wang, Jiao and Tan, Xiaolin and Wang, Xiaoyan and Wang, Yatao and Li, Hui and Yu, Zhong and Liu, Qifang},
title = {Application of Pyrrolidine in FDA‐Approved Drugs},
journal = {Medicinal Research Reviews},
year = {2026},
doi = {10.1002/med.70100}
}
EUVIMED